We are live on ! Find out more
CC

Chicago Capital Portfolio holdings

AUM $4.15B
1-Year Est. Return 31.09%
This Fund
S&P 500
This Quarter Est. Return
+17.96%
1 Year Est. Return
+31.09%
3 Year Est. Return
+117.08%
5 Year Est. Return
+137.61%
10 Year Est. Return
–
AUM
$2.24B
AUM Growth
+$294M
Cap. Flow
+$14.2M
Cap. Flow %
0.63%
Top 10 Hldgs %
30.08%
Holding
243
New
17
Increased
67
Reduced
77
Closed
14

Top Buys

Rank Stock Value
1
NFLX icon
Netflix
NFLX
+$18.8M
2
BFH icon
Bread Financial
BFH
+$17.7M
3
LAD icon
Lithia Motors
LAD
+$11.7M
4
EW icon
Edwards Lifesciences
EW
+$8.92M
5
DVAX
Dynavax Technologies
DVAX
+$8.38M

Top Sells

Rank Stock Value
1
LGND icon
Ligand Pharmaceuticals
LGND
+$14M
2
EXEL icon
Exelixis
EXEL
+$7.67M
3
KRNT icon
Kornit Digital
KRNT
+$6.23M
4
PINS icon
Pinterest
PINS
+$6.1M
5
BL icon
BlackLine
BL
+$4.54M

Sector Composition

Rank Sector Weight
1 Healthcare 21.6%
2 Financials 20.22%
3 Technology 20.08%
4 Communication Services 13.47%
5 Consumer Discretionary 8.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SO icon
201
Southern Company
SO
$109B
$311K 0.01%
5,059
+1
+0% +$60
NEE icon
202
NextEra Energy
NEE
$181B
$310K 0.01%
4,020
– –
OGE icon
203
OGE Energy
OGE
$9.78B
$296K 0.01%
9,300
– –
VOO icon
204
Vanguard S&P 500 ETF
VOO
$979B
$292K 0.01%
851
+26
+3% +$8.48K
CTAS icon
205
Cintas
CTAS
$81.9B
$288K 0.01%
3,256
– –
CHTR icon
206
Charter Communications
CHTR
$17.3B
$273K 0.01%
413
– –
SONY icon
207
Sony
SONY
$137B
$259K 0.01%
+12,830
New +$223K
PSLV icon
208
Sprott Physical Silver Trust
PSLV
$12B
$250K 0.01%
26,730
+10,730
+67% +$92.1K
ETR icon
209
Entergy
ETR
$50.2B
$249K 0.01%
4,978
– –
NVS icon
210
Novartis
NVS
$297B
$249K 0.01%
2,640
– –
VTRS icon
211
Viatris
VTRS
$20.4B
$249K 0.01%
+13,302
New +$217K
PRAA icon
212
PRA Group
PRAA
$663M
$247K 0.01%
6,220
-300
-5% -$11.9K
MTB icon
213
M&T Bank
MTB
$35.7B
$245K 0.01%
+1,923
New +$219K
MDT icon
214
Medtronic
MDT
$109B
$241K 0.01%
+2,055
New +$226K
VMC icon
215
Vulcan Materials
VMC
$34.8B
$239K 0.01%
1,609
– –
DD icon
216
DuPont de Nemours
DD
$18.5B
$238K 0.01%
+2,661
New +$209K
GILD icon
217
Gilead Sciences
GILD
$162B
$237K 0.01%
4,074
-18
-0.4% -$1.09K
MRNA icon
218
Moderna
MRNA
$21.8B
$235K 0.01%
+2,245
New +$227K
CHRW icon
219
C.H. Robinson
CHRW
$17.4B
$225K 0.01%
2,400
– –
CABO icon
220
Cable One
CABO
$227M
$223K 0.01%
+100
New +$198K
ENB icon
221
Enbridge
ENB
$119B
$221K 0.01%
6,899
-335
-5% -$10.2K
WWW icon
222
Wolverine World Wide
WWW
$1.61B
$221K 0.01%
+7,080
New +$206K
CIM
223
Chimera Investment
CIM
$1.04B
$220K 0.01%
7,167
– –
TYL icon
224
Tyler Technologies
TYL
$12.7B
$218K 0.01%
+500
New +$206K
EQIX icon
225
Equinix
EQIX
$101B
$214K 0.01%
300
-1,574
-84% -$1.17M
6 7 8
9
10

Similar funds

SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
SP
Stockbridge Partners Boston, Massachusetts $4.14B AUM 16.9% 1-Year Est. Return
BOK
Bank of Korea Seoul, South Korea $4.13B AUM
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BHC
Bowen Hanes & Co Ponte Vedra Beach, Florida $4.11B AUM 41.61% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Chicago Capital's Q4 2020 Portfolio in Review

As of Q4 2020, Chicago Capital held 243 positions worth $2.24B, up 15% from $1.95B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Chicago Capital's Q4 2020 filing shows 17 new, 67 increased, 77 reduced and 14 closed positions. Its largest new stake was Lithia Motors: 42,634 shares worth $12.5M. The largest sale was Ligand Pharmaceuticals, an estimated $14M.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 25% a quarter earlier, followed by Financials and Technology.

  • Chicago Capital's largest Q4 2020 buy was Lithia Motors: 42,634 shares worth $12.5M.
  • Chicago Capital added most to Netflix in Q4 2020, an estimated $18.8M increase.
  • Chicago Capital's biggest Q4 2020 reduction was Ligand Pharmaceuticals, cutting an estimated $14M.
  • Chicago Capital fully exited Intuitive Surgical in Q4 2020, selling an estimated $1.28M.
  • Chicago Capital's ten largest holdings make up 30% of its $2.24B portfolio in Q4 2020.
  • Chicago Capital opened 17 new positions and closed 14 in Q4 2020.
  • Chicago Capital's portfolio value rose 15% quarter-over-quarter to $2.24B.

Based on Chicago Capital's 13F filing for Q4 2020, filed 25 Jan 2021.